The distribution cost reduction plan for mid-sized pharmaceutical companies went in vain

As the pharmaceutical distribution cost reduction plan pushed ahead to improve profitability of mid-sized pharmaceutical companies went practically in vain, it is known that they have internally concerned for the issue.

According to the pharmaceutical industry, most pharmaceutical companies excluding a few top sale pharmaceutical companies recorded lower performances than the average.

The exp...